Anika Therapeutics reported $-2933000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbott ABT:US $ 2447M 458M
Acorda Therapeutics ACOR:US $ -24.52M 3.96M
Agenus AGEN:US $ -48.32M 17.19M
Agios Pharmaceuticals AGIO:US $ -94.77M 0.15M
Anika Therapeutics ANIK:US $ -2.93M 2.86M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Chemocentryx CCXI:US $ -38.61M 1.92M
Clovis Oncology CLVS:US $ -60.17M 4.22M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.48M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Immunogen IMGN:US $ -24.14M 13.03M
Insmed INSM:US $ -94621000 18.36M
Integra Lifesciences IART:US $ 32.9M 12.48M
Intrexon XON:US $ -19.25M 5.78M
Karyopharm Therapeutics KPTI:US $ -41399000 80.12M
Ligand Pharmaceuticals LGND:US $ -15.38M 9.97M
Merit Medical Systems MMSI:US $ 10.54M 10.07M
Peregrine Pharmaceuticals PPHM:US $ 2.25M 1.27M
Rigel Pharmaceuticals RIGL:US $ -27.44M 4.8M
Sangamo Biosciences SGMO:US $ -43.98M 6.48M
Stryker SYK:US $ 323M 339M
Surmodics SRDX:US $ -4.08M 1.27M
Veracyte VCYT:US $ -14.46M 3.93M
Xencor XNCR:US $ 23.59M 49.47M
Zimmer Biomet Holdings Inc ZBH:US $ 14.2M 98.2M